Ambu A/S

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

20.7.2026 12:12:39 CEST | Ambu A/S | Changes in company's own shares

On 6 May 2026, Ambu announced a share buyback program (company announcement no. 12 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.                                                                                            

During the program, Ambu will repurchase shares for a total amount of up to DKK 300m from 6 May 2026 until no later than 30 September 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.

The following transactions have been made under the program from 13 Jul 2026 to 17 Jul 2026:

 

Number of shares

Average purchase price, DKK

Transaction value, DKK

Accumulated under the program after last announcement

2,530,226

63.7877

161,397,313

2026.07.13

40,000

69.0999

2,763,997

2026.07.14

40,000

68.5741

2,742,963

2026.07.15

40,000

68.2828

2,731,313

2026.07.16

40,000

69.9327

2,797,310

2026.07.17

40,000

70.1427

2,805,709

Accumulated under the program

2,730,226

64.1847

175,238,605

 

After the above disclosed transactions DKK 124,761,395 remains to be repurchased. Ambu now owns 6,879,837 treasury shares, corresponding to 2.6% of the share capital.

Contacts

Frederik Futtrup

Associate, Investor Relations

frfu@ambu.com

Tine Bjørn Schmidt

Director of Corporate Communications

tisc@ambu.com

About Ambu A/S

Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.

Attachments

Subscribe to our company announcements

Keep up to date with our company announcements by subscribing.

Visit our pressroom and see more company announcements from us.

Our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye